This EC2 instance establishes a secure site-to-site VPN tunnel, using WireGuard, to the Raspberry Pi 5, which serves as thevhybrid node. When the tunnel is established, traffic between the Raspberry ...

Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced that Sophos Endpoint is now natively integrated and automatically included in all Taegis™ Extended ...

Sophos announced that its Endpoint security solution is now natively integrated with Taegis Extended Detection and Response (XDR) and Managed Detection and Response (MDR) subscriptions at no ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 02, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its TETON-2 ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its TETON-2 study evaluating the ...

NEW HAVEN, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend patients’ lives. A “statistically significant and clinically meaningful” ...

Findings showed inclacumab did not statistically significantly reduce the rate of VOCs compared with placebo after 48 weeks. Topline data were announced from a phase 3 study evaluating inclacumab, an ...

A new Endpoint Detection and Response (EDR) killer that is considered to be the evolution of 'EDRKillShifter,' developed by RansomHub, has been observed in attacks by eight different ransomware gangs.

VYNE Therapeutics' shares slumped ahead of the opening bell after the biopharmaceutical company ended a trial of its BET inhibitor in the treatment of vitiligo after the study failed to meet its main ...